The crude extract of the mycelium of Cladosporium was found to exhibit antimicrobial activity against the Staphylococcus aureus, methicillin-resistant S. aureus, and multidrug-resistant S. aureus. Bioassayguided fractionation of an organic extract led to the isolation of an acetophenone derivative, ...
The crude extract of the mycelium of Cladosporium was found to exhibit antimicrobial activity against the Staphylococcus aureus, methicillin-resistant S. aureus, and multidrug-resistant S. aureus. Bioassayguided fractionation of an organic extract led to the isolation of an acetophenone derivative, clavatol (2',4'-dihydroxy-3',5'-dimethylacetophenone) (1), and a benzodiazepine alkaloid, circumdatin A (2). Compound 1 showed moderate antibacterial activity against S. aureus, methicillin-resistant S. aureus, and multidrug-resistant S. aureus with minimum inhibitory concentration (MIC) values of 62.5, 62.5, 31.0 $\mu$g/mL, respectively, but compound 2 was inactive. Compounds 1 and 2 exhibited UV-A protection activity with ED$_{50}$ values of 227.0 and 82.0 $\mu$M, respectively, indicating that they were more potent than the positive control, oxybenzone (ED$_{50}$ 350 $\mu$M), a common sunscreen agent.
The crude extract of the mycelium of Cladosporium was found to exhibit antimicrobial activity against the Staphylococcus aureus, methicillin-resistant S. aureus, and multidrug-resistant S. aureus. Bioassayguided fractionation of an organic extract led to the isolation of an acetophenone derivative, clavatol (2',4'-dihydroxy-3',5'-dimethylacetophenone) (1), and a benzodiazepine alkaloid, circumdatin A (2). Compound 1 showed moderate antibacterial activity against S. aureus, methicillin-resistant S. aureus, and multidrug-resistant S. aureus with minimum inhibitory concentration (MIC) values of 62.5, 62.5, 31.0 $\mu$g/mL, respectively, but compound 2 was inactive. Compounds 1 and 2 exhibited UV-A protection activity with ED$_{50}$ values of 227.0 and 82.0 $\mu$M, respectively, indicating that they were more potent than the positive control, oxybenzone (ED$_{50}$ 350 $\mu$M), a common sunscreen agent.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
제안 방법
The connectivities and assignments of the functional groups of 2, which suggested a planar structure for this metabolite, were made by interpretation of COSY and HMBC data (Fig. 2).
, 1999). This paper describes the isolation of an acetophenone derivative, clavatol (1), a benzodiazepine alkaloid, circumdatin A (2), and the evaluation of 1 and 2 for their antibacterial and UV-A blocking properties.
데이터처리
The ultraviolet-A protecting activity was expressed as ED50, which is the concentration of the tested compound required to give a 50% increase of the absorbance from that of the blank solution [MeOH (200 µL)]. The ED50 value was determined by linear regression of data plotted on a semi-log scale.
참고문헌 (16)
Astudillo, L., Schmeda-Hirschmann, G., Soto, R., Sandoval, C., Afonso, C., Gonzalez, M.J., and Kijjoa, A., Acetophenone derivatives from Chilean isolate of Trichoderma pseudokoningii Rifai. World J. Microbiol. Biotechnol., 16, 585-587 (2000)
Barrow, C.J. and Sun, H.H., Spiroquinazoline, a novel substance P inhibitor with a new carbon skeleton, isolated from Aspergillus flavipes. J. Nat. Prod., 57, 471-476 (1994)
Doern, G.V., Pfaller, M.A., Kugler, K., Freeman, J., and Jones, R.N., Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin. Infect. Dis., 27, 764-770 (1998)
Lopez-Gresa, M.P., Gonzalez, M.C., Primo, J., Moya, P., Romero, V., and Estornell, E., Circumdatin H, a new inhibitor of mitochondrial NADH oxidase, from Aspergillus ochraceus. J. Antibiot., 58, 416-419 (2005)
Rahbaek, L. and Breinholt, J., Circumdatins, D, E, and F: further fungal benzodiazepine analogues from Aspergillus ochraceus. J. Nat. Prod., 62, 904-905 (1999)
Rahbaek, L., Breinholt, J., Frisvad, J.C., and Christophersen, C., Circumdatin A, B, and C: three new benzodiazepine alkaloids isolated from a culture of the fungus Aspergillus ochraceus. J. Org. Chem., 64, 1689-1692 (1999)
Spencer, R.C., Bauernfeind, A., Garcia-Rodriguez, J., Jarlier, V., Pfaller, M., Turnidge, J., and Ross, A., Surveillance of the current resistance of nosocomial pathogens to antibacterials. Clin. Microbiol. Infect., 3 (Suppl. 1), S21-S35 (1997)
Sun, H.H., Byard, S.J., and Cooper, R., Revised NMR assignments for the cholecystokinin antagonist asperlicin. J. Antibiot., 47, 599-601 (1994), and references therein
Weber, D., Gorzalczany, S., Martino, V., Acevedo, C., Sterner, O., and Anke, T., Metabolites from endophytes of the medicinal plant Erythrina crista-galli. Z. Naturforsch., 60c, 467-477 (2005)
Zhang, D., Yang, X., Kang, J.S., Choi, H.D., and Son, B.W., Chlorohydroaspyrones A and B, antibacterial aspyrone derivatives from the marine-derived fungus Exophiala sp. J. Nat. Prod., 71, 1458-1460 (2008a)
Zhang, D., Yang, X., Kang, J.S., Choi, H.D., and Son, B.W., Circumdatin I, a new ultraviolet-A protecting benzodiazepine alkaloid from a marine isolate of the fungus Exophiala. J. Antibiot., 61, 40-42 (2008b)
※ AI-Helper는 부적절한 답변을 할 수 있습니다.